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Introduction: In Ethiopia, there is a lack of data on pneumococcal serotypes causing acute otitis media (AOM) in
children. We aimed to study the etiology, pneumococcal serotypes and antimicrobial resistance patterns of
isolates from children with AOM with spontaneous perforation of the tympanic membrane (SPTM).
Methods: We carried out a prospective observational study in children with AOM with SPTM, aged 0–15 years in
Addis Ababa, Ethiopia. Middle ear ﬂuid was collected using sterile swabs, cultured and antibiotic susceptibility
testing was performed. Serotypes of Streptococcus pneumoniae were determined by sequencing the cpsB gene and
by the Quellung reaction.
Results: A total of 55 children were enrolled. Out of 55 samples that were cultured, 52 (94.5%) were culture
positive for a total of 66 bacterial species, and 56.4% (31/55) samples were positive for 41 (62.1%) known
pathogenic bacterial species. The most common pathogenic bacterial isolates were S. pneumoniae (36.6%),
Staphylococcus aureus (19.5%), Streptococcus pyogenes (14.6%) and Haemophilus inﬂuenzae (12.2%). Serotype 19A
(73.3%) was the predominant pneumococcal serotype. There was a high rate of non-susceptibility to penicillin
(86.6%) and trimethoprim/sulfamethoxazole (80%) among pneumococcal isolates. Out of 21 diﬀerent isolates
tested for amoxicillin susceptibility, 15 (71.4%) were resistant.
Conclusions: Pneumococcal serotype 19A was the predominant cause of AOM with SPTM in children in Addis
Ababa, Ethiopia, 5 years after introduction of PCV10. There was a high rate of resistance to commonly pre-
scribed antibiotics. The study highlights the need for wide scale surveillance of the etiology and antimicrobial
susceptibility of AOM in Ethiopian children.
1. Background
Acute otitis media (AOM) is a very common childhood condition,
known to be the leading cause of outpatient visits and the leading in-
dication for antibiotic prescription [1]. It is estimated that 709 million
cases occur each year, half of them in children<5 years of age [2].
Streptococcus pneumoniae, Haemophilus inﬂuenzae and Moraxella
catarrhalis are the predominant bacterial causes of AOM [3]. The in-
troduction of the pneumococcal conjugate vaccine (PCV) has however
resulted in signiﬁcant reduction in the incidence of AOM due to vac-
cine-type pneumococci [4] and an increase in the proportion of H.
inﬂuenzae [5].
Before the widespread use of PCVs, pneumococcal serotypes 1, 3, 5,
12F, 19A and 19F were signiﬁcantly associated with AOM [6]. In-
troduction of PCV7, and subsequently of PCV10 increased the im-
portance of serotypes 3 and 19A [7,8]. Introduction of PCV13 resulted
in a signiﬁcant decline of AOM caused by PCV13 serotypes [9–11].
Although the gold standard method for identiﬁcation of etiological
agents of AOM is obtaining middle ear ﬂuid (MEF) through tympano-
centesis, the procedure is painful, and is not performed routinely, but
MEF can easily be obtained from the ear discharge in children with
spontaneous perforation of the tympanic membrane (SPTM) [12].
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Studies performed in European countries and in Australian children
indicated that only 5–30% of AOM cases presented with SPTM [13,14].
A study on 529 children with tympanic membrane perforation in Ni-
geria reported that 28.4% of the cases were due to AOM [15].
Previous studies in Ethiopia have reported Staphylococcus aureus to
be the most common cause of otitis media [16,17]. PCV10 was in-
troduced without a catchup campaign in Ethiopia in 2011 as a 3 dose
primary series at 6, 10, and 14 weeks of age and no booster dose
(3p + 0) [18]. There is lack of data on the distribution of pneumococcal
serotypes causing acute otitis media in Ethiopia. The aim of the study
was to determine the etiology, antimicrobial susceptibility, pneumo-
coccal serotypes distribution and their role as a cause of pediatric AOM
with SPTM in Addis Ababa, Ethiopia, 5 years after introduction of
PCV10 in the country.
2. Methods
2.1. Study setting
This prospective observational study was carried out at three health
care facilities which provide outpatient pediatric services (Yekatit 12
Hospital, Girum Hospital and Dr. Yared Pediatric Specialty Center) in
Addis Ababa, Ethiopia.
2.2. Patient recruitment and data collection
Patient identiﬁcation and recruitment was carried out from
September 1, 2016 to August 30, 2017. Children aged 0–15 years with
AOM and spontaneous otorrhea (tympanic membrane perforations oc-
curring within 24 h prior to the hospital visit), as conﬁrmed by a pe-
diatrician after otoscopic examination were enrolled in the study. AOM
was diagnosed based on the presence of at least one of the following
symptoms: Otalgia/irritability and fever with inﬂamed tympanic
membranes. A structured questionnaire was used to obtain socio-
demographic and clinical data.
2.3. Laboratory procedures
2.3.1. Sample collection
Middle ear discharges were carefully collected by pediatricians and
trained nurses. The middle ear was carefully swabbed using sterile
swabs after the external auditory canal was cleaned. The swabs were
then transferred into Amies agar gel with charcoal transport media
(Oxoid, Cheshire, England). Samples were transported to Armauer
Hansen Research Institute (AHRI) and processed within 16 h of col-
lection.
2.3.2. Culture and identiﬁcation
Swabs were streaked and plated onto Blood Agar (BA), Blood Agar
with 2.5 mg of gentamicin per liter (BA + G), Chocolate Agar (CA) and
MacConkey Agar (MA) (Oxoid). BA, BA + G and CA plates were in-
cubated in ~5% CO2, whereas MA plates were incubated aerobically at
37 °C for 18–24 h. Initial identiﬁcation of bacteria was carried out at the
Armauer Hansen Research Institute (AHRI), Addis Ababa, Ethiopia, by
Gram stain, hemolytic activity on sheep blood agar plates, optochin
sensitivity, bile solubility, coagulase test, colony morphology on MA
and growth on Mannitol Salt Agar. Further identiﬁcation was then
performed on all isolates by Matrix-assisted laser desorption/ionization
time of ﬂight mass spectrometry (MALDI-TOF MS) at the Laboratory
Bacteriology Research (LBR), Ghent University, Ghent, Belgium.
2.3.3. Antibiotic susceptibility testing
Susceptibility testing was performed on a selected panel of anti-
biotics that are used locally by means of the Kirby-Bauer disk diﬀusion
method [19]. For pneumococcal isolates, penicillin resistance was in-
itially measured using oxacillin discs and for isolates with zones
≤19mm, minimum inhibitory concentrations (MICs) were determined
using E-Test strips (bioMerieux, Marcy-l’Etoile, France) and the results
were classiﬁed as: susceptible (≤0.06 μg/mL), intermediate
(0.12–1 μg/mL) and resistant (≥2 μg/mL). Test results of both disc
diﬀusion and MICs were interpreted according to the Clinical and La-
boratory Standard Institute (CLSI) criteria [20] and European Com-
mittee on Antimicrobial Susceptibility Testing (EUCAST) [21]. The
following reference strains were used as controls: Escherichia coli ATCC
25922, S. aureus ATCC 25923 and S. pneumoniae ATCC 49619.
2.3.4. DNA extraction and ampliﬁcation of lytA
DNA extraction from S. pneumoniae isolates was carried out by al-
kaline lysis as described previously [22]. Ampliﬁcation of a 101-bp
fragment of the lytA gene was carried out as previously described [23].
2.3.5. PCRSeqTyping and serotyping
PCRSeqTyping was performed by amplifying and sequencing the
cpsB gene as previously described [24]. Twenty μl of the amplicons
were sent for sequencing to GATC Biotech (Constance, Germany) and
sequencing was performed using the Sanger sequencing technique. cpsB
sequences were used to search the GenBank database (http://www.
ncbi.nlm.nih.gov/blast). Serotype was assigned based on a BLAST bit
score of> 99% sequence identity of the query cpsB nucleotide sequence
with the reference sequences from GenBank. Because the correct ser-
otype could not be assigned by PCRSeqTyping for four of the isolates
and cpsB could not be ampliﬁed for one more, serotyping of these iso-
lates was performed by the Quellung reaction [25] using pool and
group antisera, obtained from the Statens Serum Institut (Copenhagen,
Denmark) at the Belgian Pneumococcal Reference Laboratory, Uni-
versitair Ziekenhuis KUL, Leuven.
2.4. Statistical analysis
Data were analyzed using Excel. Continuous variables were ex-
pressed in terms of median and interquartile range (IQR), whereas ca-
tegorical variables were expressed as frequencies and percentages.
2.5. Ethical approval
The study was approved by the AHRI/All Africa Leprosy
Rehabilitation and Training Hospital (ALERT) Ethics Review
Committee, Addis Ababa University Institutional Review Board, Yekatit
12 Medical College Ethics Committee and the National Research Ethics
Review Committee (No. 310/194/2017). Written informed consent was
obtained from parents/guardians of all participants before collection of
samples.
3. Results
3.1. Characteristics of study participants
A total of 55 children with AOM with otorrhea were enrolled. The
median age of children was 37.5 (IQR, 10–52) months and 56.4% were
male (Table 1). Most of them (82.6%) were under 5 years of age. Most
of the children (89.1%) had received at least one dose of PCV10 and
80% had been fully vaccinated. The most common symptom reported
was otalgia (80%).
3.2. Bacterial etiology
Out of 55 samples that were cultured, 52 (94.5%) were culture
positive. A total of 66 bacterial species were isolated out of which 41/
66 (62.1%) were known pathogens from 31 (56.4%) of the cases. The
most common pathogenic bacterial isolates were S. pneumoniae
(36.6%), S. aureus (19.5%), Streptococcus pyogenes (14.6%) andH. in-
ﬂuenzae (12.2%) (Table 2).
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Other bacteria, considered as non-pathogenic, included: coagulase
negative staphylococci (n= 4), Enterobacter cloacae (n= 3),
Corynebacterium amycolatum (n= 2), Klebsiella oxytoca (n= 2), Proteus
vulgaris (n= 2), Streptococcus oralis (n= 2), Acinetobacter pittii (n= 1),
Bacillus safensis (n= 1), Brevundimonas diminuta (n= 1),
Corynebacterium pseudodiphtheriticum (n= 1), Enterococcus casseliﬂavus
(n= 1), Exiguobacterium aurantiacum (n= 1), Lysinibacillus fusiformis
(n= 1), Pseudomonas stutzeri (n= 1), Streptococcus mitis (n= 1) and
Wautersiella falsenii (n= 1).
Mixed pathogenic bacterial infections were recorded in 8/55
(14.5%) of the patients with the most common being co-infection with
S. pneumoniae and S. aureus (n= 3) (Table 3). Mixed infections of
known pathogenic and other bacteria, usually considered as non-pa-
thogenic, have also be detected in 5/55 (9.1%) additional cases. Finally,
there was one case of mixed non-pathogenic bacterial species, Cor-
ynebacterium amycolatum/Enterobacter cloacae.
3.3. Antibiotic susceptibility
The prevalence of non-susceptibility to penicillin among S. pneu-
moniae isolates was 86.7% (13/15), with two being resistant and 11
intermediate (Table 4). For other antibiotics, 33.3% of the strains were
resistant to erythromycin, 60% to tetracycline and 80% to trimetho-
prim/sulfamethoxazole, while none were resistant to chloramphenicol.
Among S. aureus isolates, all were resistant to amoxicillin and 37.5%
were resistant to amoxicillin-clavulanate, whereas all were susceptible
to ceftriaxone and gentamicin. Among S. pyogenes isolates, 33.3% were
resistant to amoxicillin, amoxicillin-clavulanate, ceftriaxone and ery-
thromycin and 50% were resistant to tetracycline, whereas 100% were
susceptible to chloramphenicol.
Among Gram negatives, 60% of H. inﬂuenzae isolates were resistant
to amoxicillin and 40% were resistant to erythromycin and trimetho-
prim/sulfamethoxazole each. Only 20% were resistant to amoxicillin-
clavulanate. Among K. pneumoniae isolates, all were resistant to
amoxicillin and 50% were resistant to amoxicillin-clavulanate.
3.4. Pneumococcal serotypes
The majority of the pneumococcal isolates (93.3%) were non-PCV10
serotypes with the predominant one being serotype 19A (Table 5).
PCV10 vaccine coverage for the serotypes in circulation was therefore
only 6.7% and PCV13 would increase the serotype coverage to 80%.
4. Discussion
To the best of our knowledge, this is the ﬁrst study in Ethiopia that
described the pneumococcal serotypes causing AOM with SPTM in
children. We found that 56.4% of the cases were positive for at least one
otopathogen. Overall, S. pneumoniae (36.6%) was the most common
bacterial pathogen in accordance with similar studies in China,
Argentina and Russia [26–28]. All these studies however were per-
formed before the introduction of PCV in these countries. Our results
were however contrary to the results of a study performed after the
introduction of PCV10 in Australia [29], in which H. inﬂuenzae was the
most common cause of AOM with SPTM rather than S. pneumoniae as in
our case.
Among the 15 S. pneumoniae isolates, we identiﬁed 4 diﬀerent ser-
otypes plus non-typeable isolate. The predominant pneumococcal ser-
otype was 19A in 11 out of 15 isolates. Serotype 19A, along with 3 and
19F, has been identiﬁed as the most common serotype in a post-PCV10
study in samples obtained by tympanocentesis and from children with
AOM with SPTM in Bulgaria [8].
S. aureus (19.5%) was the second most common isolate in this study
in accordance with similar studies on AOM with SPTM in China [26]
and Taiwan [30]. In a previous study from Mekelle, Ethiopia, S. aureus
(18.75%) was the most common pathogen isolated from children with
AOM with SPTM [17]. S. aureus is not a common cause of AOM spe-
cially in uncomplicated cases and since S. aureus is a common colonizer
of the skin, it is often diﬃcult to establish its causative role in both
uncomplicated AOM and AOM with SPTM [31]. Further studies are
therefore required to determine the role of S. aureus in both AOM with
and without SPTM in Ethiopia.
Only 13.3% (2/15) of the S. pneumoniae isolates were resistant to
penicillin while most, 73.3% (11/15) were intermediate. Previous
studies on isolates from children with OM in Ethiopia have reported
Table 1
Sociodemographic and clinical characteristics of 55 children with AOM with
SPTM aged 0–15 yrs.
Variable Category No %
Gender Male 31 56.4
Female 24 43.6
Age 28 days −1 yr 23 41.8
2 yrs–5 yrs 22 40.0
≥6 yrs 10 18.2
Premature birth Yes 10 18.2
Breastfeeding Yes 25 45.5
Has siblings aged < 5 yrs Yes 18 32.7
Day care/pre-school attendance Yes 14 25.5
Parental smoking Yes 7 12.7
Vaccination 1st dose only 1 1.8
2nd dose only 4 7.3
3rd (full) dose 44 80
Non-vaccinated 6 10.9
Nutritional status Well-nourished 44 80
Moderately malnourished 6 10.9
Severely malnourished 5 6.1
Signs and symptoms Fever 35 63.6
Otalgia 44 80
Red and swollen eardrum 42 76.4
Sleeplessness 25 45.5
Irritability 25 45.5
Table 2
Distribution of cultured pathogenic bacterial species from 55 children with
AOM with SPTM in Addis Ababa, Ethiopia.
Pathogenic Bacterial Species No. %
Streptococcus pneumoniae 15 36.6
Staphylococcus aureus 8 19.5
Streptococcus pyogenes 6 14.6
Haemophilus inﬂuenzae 5 12.2
Klebsiella pneumoniae 2 0.5
Pseudomonas aeruginosa 2 0.5
Acinetobacter baumannii 1 0.24
Moraxella catarrhalis 1 0.24
Proteus mirabilis 1 0.24
Total 41 100
Table 3
Co-infections with pathogenic bacterial species in children with AOM with
SPTM in Addis Ababa, Ethiopia.
Mixed pathogenic isolates No.
Streptococcus pneumoniae/Staphylococcus aureus 3
Streptococcus pneumoniae/Staphylococcus aureus/Acinetobacter baumannii 1
Streptococcus pneumoniae/Haemophilus inﬂuenzae 1
Streptococcus pneumoniae/Pseudomonas aeruginosa 1
Staphylococcus aureus/Haemophilus inﬂuenzae 1
Staphylococcus aureus/Moraxella catarrhalis 1
Mixed pathogenic and other non-pathogenic isolates
Streptococcus pneumoniae/Brevundimonas diminuta 1
Proteus mirabilis/Klebsiella oxytoca 1
Haemophilus inﬂuenzae/Streptococcus oralis 1
Haemophilus inﬂuenzae/Exiguobacterium aurantiacum 1
Streptococcus pyogenes/Enterobacter cloacae 1
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penicillin non-susceptibility rates of 66.7% [32] and 93% [17] based on
disc diﬀusion. In our study, the non-susceptibility rate based on disc
diﬀusion is 86.7% (13/15). Our MIC test results however indicate that
most of the isolates which were non-susceptible with disc diﬀusion,
84.6% (11/13) were intermediate. Our results are consistent with
previous reports from South Africa [33] and Japan [34] in which the
resistance of S. pneumoniae to penicillin was mainly intermediate.
Among S. aureus isolates, 100% were resistant to amoxicillin, the
ﬁrst line antibiotic according to the Ethiopian standard treatment
guideline [35]. The limited level of resistance to the second line anti-
biotics, amoxicillin-clavulanate and erythromycin however means that
they could still be used as treatment options. H. inﬂuenzae, the most
common isolate among Gram-negatives in this study, showed sub-
stantial level of resistance to the ﬁrst line antibiotics, amoxicillin (60%
of the isolates). Since the resistance to ampicillin is often mediated by a
TEM-1 β-lactamase, an enzyme susceptible to inhibition by clavulanic
acid, the use of amoxicillin-clavulanate has been reported to restore
susceptibility rates to 100% [36]. In general, our results indicate the
need for continued surveillance of the changing etiology and antibiotic
resistance in the post-PCV10 period.
Our study had some limitations. The number of cases was low and
more patients and data would have been useful for our analysis.
Unfortunately, because tympanocentesis is not routinely performed in
Ethiopia, we could only collect samples from children with SPTM. The
isolates may therefore not be representative of the full acute otitis
media spectrum.
5. Conclusions
In conclusion, pneumococcal serotype 19A was the most common
cause of AOM with SPTM in children in Addis Ababa, Ethiopia, ﬁve
years after introduction of PCV10. There was a substantial level of re-
sistance against ﬁrst-line antibiotics and a considerable resistance
against second-line antibiotics. Our results therefore highlight the need
for a continued surveillance of the etiology and antimicrobial suscept-
ibility of AOM.
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